Great Novel Therapeutics Biotech & Medicals Corporation

πŸ‡ΉπŸ‡ΌTaiwan
Ownership
-
Employees
-
Market Cap
-
Website

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

First Posted Date
2023-04-27
Last Posted Date
2024-02-26
Lead Sponsor
Great Novel Therapeutics Biotech & Medicals Corporation
Target Recruit Count
33
Registration Number
NCT05833724
Locations
πŸ‡¨πŸ‡³

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

πŸ‡¨πŸ‡³

National Taiwan University Hospital, Taipei, Taiwan

πŸ‡¨πŸ‡³

Chang Gung Memorial Hospital, Kaohsiung, Kaohsiung, Taiwan

and more 2 locations

Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)

First Posted Date
2023-03-16
Last Posted Date
2024-02-23
Lead Sponsor
Great Novel Therapeutics Biotech & Medicals Corporation
Target Recruit Count
46
Registration Number
NCT05770882
Locations
πŸ‡¨πŸ‡³

National Cheng Kung University Hospital, Tainan, Taiwan

πŸ‡¨πŸ‡³

Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan

πŸ‡¨πŸ‡³

China Medical University Hospital, Taichung, Taiwan

and more 2 locations
Β© Copyright 2024. All Rights Reserved by MedPath